COST OF EPIDIOLEX VS WHOLE PLANT CANNABIS FOR TREATMENT RESISTANT EPILEPSY

As many of you have heard, Epidiolex, a nearly pure CBD anti-epileptic made by GW Pharmaceuticals has been approved by the FDA and will probably launch sales mid 2019.

The cost for an average patient for one year is over $32,000.

This is on par with other anti-epileptics, but is certainly an astonishing cost when you compare this cost to the cost of whole plant CBD at it’s therapeutic dose.

I specifically say “whole plant cannabis” because it always requires far less CBD than CBD isolates, and Epidiolex is no exception although not a pure isolate. So when comparing cost, it is essential to compare to the average cost of whole plant CBD at the dose where it is effective. In my experience, I very rarely use more than 100 mg per day in divided doses sublingually for intractable seizures.

Not only is whole plant cannabis less expensive at around $5,000 per year, it requires a lower dose and I believe, as with other whole plant vs “isolate” studies, the whole plant CBD will prove to be more effective.

This may have a huge impact on the stock, as the more patients who go “whole plant”, the less sales to GW. Even with insurance paying for it, it is likely the co-pay will be as much as the whole plant cost for the year.

I suppose this is good news for the “artisanal” cannabis medicine creator, but if less and less CBD is available and so few doctors are involved, the Pharmaceutical route may still win out.

http://globenewswire.com/news-release/2018/08/07/1548402/0/en/GW-Pharmaceuticals-plc-Reports-Fiscal-Third-Quarter-2018-Financial-Results-and-Operational-Progress.html

Author
Allan Frankel, MD Dr Allan Frankel is one of the few physicians in the US who truly understands Cannabis as a medicine. All treatments suggested have been well studied. Every patient seen by Dr Frankel is given a personally created Treatment Plan created with the patient's specific issues defined. Plant medicine requires "tuning" of the dosing. Dr Frankel works with his patients thru a messaging portal. The use of this portal, allows quick and simple follow up contact with Dr Frankel. Patients are not charged for these messages, as this is how Dr Frankel has learned what he has learned. Follow up appointments in person or by phone/video are also available when needed

You Might Also Enjoy...

OUTSTANDING RESULTS FOR SEVERE PAIN

Below is a recent testimonial from a long-term patient of mine. He survived a horrendous fall many years ago, and has endured severe, crippling, chronic pain. In his letter, he briefly describes his journey, progress, and success with consistently dosed

CBD DOSING: WHEN IS LESS… MORE?

Dr Frankel talks about the differences in dosing single molecule CBD versus whole plant CBD. He also talks about potential health and drug interaction issues with taking high doses of single molecule CBD.

DO I ADVISE CANNABIS FOR EVERY PATIENT?

Dr Frankel talks about if he always recommends cannabis to the patients he sees and brings up a specific case where he used his internal medicine and diagnostic skills to treat a patient without cannabis therapies.

THC-A  AND MITOCHONDRIA

Dr Frankel talks about THC-A, conditions he is using it for and how it most likely has a very powerful relationship with our mitochondria.